Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/41055, first published .
High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study

High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study

High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study

Journals

  1. Evenepoel P, Jørgensen H. Hypocalcemia: a cardiovascular risk factor coming of age?. Nephrology Dialysis Transplantation 2024;39(4):557 View
  2. Ouchi R, Nagao M, Suzuki S, Yamagata T, Chiba M, Kurata N, Usui K, Watanabe T, Koyama K, Okada K. A case with a trend of QT interval prolongation due to the introduction of methadone to a pancreatic cancer patient on levofloxacin. Journal of Pharmaceutical Health Care and Sciences 2024;10(1) View
  3. Hamid A, Pastor Arroyo E, Calvet C, Hewitson T, Muscalu M, Schnitzbauer U, Smith E, Wagner C, Egli-Spichtig D. Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid–Induced AKI. Journal of the American Society of Nephrology 2024;35(3):261 View